+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06889623

Study of Immediate Cisplatin and Gemcitabine Chemotherapy After Surgery for High-Risk Non-Muscle-Invasive Bladder Cancer

Led by Changhai Hospital · Updated on 2025-03-21

72

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the safety and effectiveness of giving systemic chemotherapy immediately after surgery in patients with suspected high-risk non-muscle-invasive bladder cancer NMIBC. This type of bladder cancer often recurs, and residual tumors or floating tumor cells after standard surgery may increase this risk. The study aims to see if chemotherapy given within 24 hours after tumor removal can reduce recurrence and improve patient outcomes. Participants will receive chemotherapy with cisplatin and gemcitabine through an intravenous infusion within 24 hours after their transurethral resection of bladder tumor TURBT surgery. Fluid samples will be collected before and after surgery and chemotherapy to assess tumor changes. Following this, patients will undergo one year of intravesical Bacillus Calmette-Gurin BCG treatment according to guidelines, with regular imaging and cystoscopic exams to monitor their condition. Throughout the study, researchers will monitor recurrence-free survival over one year, pathological changes 2-6 weeks after chemotherapy, and any serious side effects. They will also evaluate chromosomal instability using UroCAD testing around 15 days post-surgery. Participants will be closely followed with imaging and bladder examinations, with the total follow-up period lasting approximately two years to assess long-term effects and safety.

CONDITIONS

Brief Title

Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

Research Team

S

Shuxiong Zeng, M.D. Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here